Global Pediatric Vaccines Market Share, Size, Top Manufacturers, Forecast 2023-2028

The latest research study "Pediatric Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" by IMARC Group, finds that the global pediatric vaccines market size reached US$ 34.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 54.9 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.

Pediatric vaccines, also known as immunizations, are medical products designed to create immunity in infants, children, and adolescents against various diseases. These vaccines are available in both single and multiple antigen versions and are commonly used in departments such as cardiology, critical care, oncology, and pulmonology. By protecting against serious illnesses like measles, brain swelling, polio, paralysis, diarrhea, and hepatitis, pediatric vaccines help promote a healthier life and protect children against infectious and non-infectious diseases. They are effective, safe, and play a crucial role in preventing and managing diseases in children.

Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/pediatric-vaccines-market/requestsample

Pediatric Vaccines Market Trends and Drivers:

The rise in the prevalence of chronic diseases is one of the primary factors driving the growth of the pediatric vaccines market. The development of safe and effective vaccines that prevent the spread of dangerous illnesses among children further enhances market growth. Additionally, the introduction of new vaccines for the treatment of relapsing forms of multiple sclerosis in children and adolescents is fueling market growth. The need to promote public health and the cost-effectiveness of vaccines as a means of improving welfare across countries are also significant growth factors. The demand for conjugate vaccines that stimulate immunological memory and reduce bacterial carriage is also contributing to market growth. Increased awareness of early disease detection and prevention, growing R&D activities, and government policies to encourage vaccination administration are expected to propel market growth in the coming years.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/pediatric-vaccines-market

Pediatric Vaccines Market 2023-2028 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Abbott Laboratories, Bio-Med Private Limited, Daiichi Sankyo Company Limited, GSK plc, Indian Immunologicals Limited (National Dairy Development Board), Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation), Panacea Biotec Limited, Pfizer Inc., Sanofi S.A. and Sinovac Biotech Ltd.

The report has segmented the market on the basis of type, technology and application.
Breakup by Type:

• Multivalent
• Monovalent

Breakup by Technology:

• Conjugate
• Live Attenuated
• Inactivated
• Subunit
• Toxoid
• Others

Breakup by Application:

• Infectious Disease
• Cancer
• Allergy
• Others

Breakup by Region:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Key highlights of the report:

• Market Performance 
• Market Outlook 
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.